To the Editor Background
Numerous studies introduced epidermal keratinocytes as "non-classical" immunecompetent cells, hence potent primary regulators and active participants of cutaneous immune functions (1, s1-6) . Therefore, targeting them might provide a novel, highly specific anti-inflammatory therapeutic possibility. The endocannabinoid system (ECS) is an emerging signaling network which regulates multiple cutaneous functions (2, 3) . The loss of homeostatic endocannabinoid (eCB) signaling of epidermal keratinocytes was shown to dramatically enhance inflammatory processes, arguing for that the cutaneous eCB tone plays a "gate-keeper" role in the initiation phase of skin inflammation (4; for further details see Supplementary Background section). Moreover, elevation of the eCB tone, e.g. by the inhibition of fatty acid amide hydrolase (FAAH), the most important enzyme engaged with the degradation of the eCB anandamide (AEA; 5), exerts ECSmediated anti-inflammatory actions in multiple organs (5) .
Questions addressed
Based on these data we hypothesized that up-regulation of expression/activity of FAAH (thereby decreasing the eCB tone, and increasing the level of the pro-inflammatory "eCB degradation product" arachidonic acid [AA] ) might contribute to the development of the inflammatory processes. Therefore, we aimed at investigating (i) mRNA and protein 
Experimental design
Detailed description of the methods can be found in the Supplementary Experimental design section.
Cell culture
Human skin samples were obtained after obtaining written informed consent from 
Determination of cellular viability, apoptosis and necrosis
Viability and cell death were determined by MTT and DilC 1 (5)-SYTOX Green assays as described previously (s11).
Expression analysis
Molecular expression was monitored by Q-PCR and Western blot as described previously with slight modifications (s11). The released amount of IL6 and IL8 was 
Determination of the FAAH-activity
The enzymatic activity of FAAH in NHEKs and HPV-KERs homogenates was assessed by determination of the hydrolysis of [ethanolamine- [1] [2] [3] H]AEA as previously described (s12-16).
Experiments on NC/Tnd mice
The study was conducted at BioTox Sciences (BTS; San Diego, CA, USA). The study design and animal usage were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC; No. 1109-05). Clinical score was determined from observations of the upper back/lower neck with a scale of 0-3 (0: absent; 1: mild; 2: moderate; 3: severe) for erythema, edema or papulations, and for oozing, crusts or hemorrhages. Each mouse received a single daily topical dose that was applied to the upper back/lower neck area.
Statistical analysis
Data were analyzed and graphs were plotted by using Origin Pro Plus 6.0 software (Microcal, Northampton, MA, USA), using Student's two-tailed two samples t-test and
P<0
.05 values were regarded as significant differences. 
Results
We found that FAAH is expressed in HPV-KERs both at the mRNA and protein levels (Supplementary Figure S2; Figure 1a-b) . Importantly, we also found that upon administration of TLR2 or -4-activators (lipoteichoic acid [LTA] and lipopolysaccharide
[LPS], respectively), expression of FAAH at the protein level tended to be increased. Interestingly, at the mRNA level, only 3-hr LPS treatment induced significant increase (Figure 1a-b; Supplementary Figure S2) , and in NHEKs, only LTA was able to enhance the expression (Figure 1c-d) . Importantly, both HPV-KERs and NHEKs exhibited significant elevations in FAAH-activity upon TLR2-activation (Figure 1e-f) . The above findings raised the possibility that the decreased eCB mediated by FAAH upregulation might theoretically contribute to the development of the TLR-activationinduced pro-inflammatory responses in the human skin. To challenge this hypothesis, next, we investigated the putative anti-inflammatory effects of selective FAAH-inhibitors, by monitoring the production of key pro-inflammatory cytokines (IL1A, IL1B, IL6 and IL8; s17-19). As expected, both the commercially available FAAH-inhibitor URB597 (s20), as well as novel inhibitors (WOBE440 and WOBE479) almost completely prevented the LTA-induced up-regulation of the aforementioned cytokines (Figure 2a-b) . Importantly, they also significantly suppressed the LTA-induced release of IL6 and IL8 (Figure 2c-d) .
FAAH-inhibitors exert their effects via the elevation of the local AEA tone, which subsequently activates CNR1 and CNR2 (5) . In a good agreement with the literature data (4), combined antagonism of these receptors markedly abolished the antiinflammatory actions of the FAAH-inhibitors (Supplementary Figure S3) . Importantly, concentrations of FAAH-inhibitors having been proven to exert anti-inflammatory actions (i.e. 100 and 200 nM for WOBE440 and WOBE479, respectively) did not induce any 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 HaCaT keratinocytes in a CNR1 receptor-dependent manner (s7). Further, one of the key eCBs (i.e. anandamide; AEA) exhibited anti-allergic/anti-inflammatory effects in human skin, which could be abolished by CNR1 receptor inverse agonists falcarinol and rimonabant. These data, together with recent findings that activation of CNR1 in epidermal keratinocytes attenuated FITC-induced "atopic-like" dermatitis in a mouse model (s8), and that it limited the secretion of pro-inflammatory chemokines regulating T cell-dependent inflammation in the effector phase of contact hypersensitivity (s9), short trypsin (0.05%, Sigma-Aldrich) digestion. Cells were cultivated at 37°C in humidified, 5% CO 2 containing atmosphere, the medium was changed every other day, and cells were sub-cultured at 70-80% confluence in both cases.
Determination of cellular viability
The viability of the cells was determined by measuring the conversion of the tetrazolium salt MTT (Sigma-Aldrich) to formazan by mitochondrial dehydrogenases. Cells were plated in 96-well plates (20,000 cells/well) in quadruplicates, and were cultured for 8, 24
or 72 hours. Cells were then incubated with 0.5 mg/ml MTT for 2 hrs, and concentration of formazan crystals (as an indicator of number of viable cells) was determined colorimetrically as described previously (s10-11). Results were expressed as percentage of vehicle controls regarded as 100%. When applicable, curve fitting was performed by
Origin Pro Plus 6.0 software (Microcal, Northampton, MA, USA) using "Exponential Decay 1" curve fitting option. 
Western blotting
Cells were harvested in lysis buffer (20 mM Tris-HCl, pH 7.4, 5 mM EGTA, 1 mM 4-(2-aminoethyl) benzensulfonyl fluoride, protease inhibitor cocktail diluted 1:100, (all from Sigma-Aldrich) and the protein content was measured by a modified BCA protein assay (Pierce, Rockford, IL, USA). The samples were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 10% Mini Protean TGX gels (Bio-Rad, 
Determination of apoptosis
A decrease in the mitochondrial membrane potential is one of the earliest markers of apoptosis. Therefore, to assess the process, mitochondrial membrane potential of HPV- severe) for erythema, edema or papulations, and for oozing, crusts or hemorrhages.
Each mouse received a single daily topical dose that was applied to the upper back/lower neck area. The study was run in two equal halves, each starting with N=4-5 animals. Evaluation of total disease score and measurement of ear thickness was performed as indicated (twice a week).
Determination of cytokine release (ELISA)
Cells were treated as indicated for 24 hours. Supernatants were collected, and the released amount of IL6, and IL8 was determined using OptEIA kits (BD Pharmingen, For chronic cutaneous inflammatory diseases, there is still a need for the development of novel, efficient and safe topical drugs with an improved benefit-risk profile as compared to topical corticosteroids or calcineurin inhibitors. It is widely accepted that in cutaneous inflammatory diseases (e.g. in AD), dysregulation of the local, cutaneous immune system impairs the physico-chemical skin barrier, thereby greatly contributing to the progression of the disease and the worsening of the symptoms (s27-28).
Although epidermal expression of FAAH was described long ago (s29), our data are the first ones arguing for that this enzyme, via decreasing the anti-inflammatory eCB tone (and on the other hand, subsequently increasing concentration of the pro-inflammatory "AEA degradation product" AA) shifts the AEA/AA steady-state towards a proinflammatory direction (Supplementary Figure 7a-b) .
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